BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/15/2026 10:18:00 AM | Browse: 3 | Download: 0
Publication Name World Journal of Stem Cells
Manuscript ID 116184
Country South Korea
Category Neurosciences
Manuscript Type Review
Article Title Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions
Manuscript Source Invited Manuscript
All Author List Sara Akhtar Khan, Prakash Gangadaran, Prachi Tiwari, Ramya Lakshmi Rajendran, Azfar Jamal, Shaheenkousar H Hattiwale, Kushi Anand, Saurabh Kumar Jha, Chae Moon Hong, Byeong-Cheol Ahn and Suhel Parvez
Funding Agency and Grant Number
Funding Agency Grant Number
National Research Foundation of Korea Basic Science Research Program NRF-2022R1I1A1A01068652
Corresponding Author Byeong-Cheol Ahn, Department of Nuclear Medicine, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, South Korea. abc2000@knu.ac.kr
Key Words Mesenchymal stem cell-derived extracellular vesicles; Pain management; Drug delivery; Biomarkers; Immunomodulation; Nociceptor sensitization
Core Tip This review summarizes the mechanistic and translational evidence on how mesenchymal stem cell-derived extracellular vesicles (EVs) coordinately regulate inflammation, immunity and nociceptor sensitization to reduce pain. However, clinical advances are impeded by various factors like non-standardized EV isolation, indistinct dosing and regulatory constraints, hindering therapeutic validation process. Next generation EV engineering techniques, targeted cargo loading and scalable production approaches offer promise for future mesenchymal stem cell-derived EV therapies targeting chronic and refractory pain conditions.
Citation Khan SA, Gangadaran P, Tiwari P, Rajendran RL, Jamal A, Hattiwale SH, Anand K, Jha SK, Hong CM, Ahn BC, Parvez S. Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions. World J Stem Cells 2026; In press
Received
2025-11-05 05:51
Peer-Review Started
2025-11-05 05:51
First Decision by Editorial Office Director
2025-11-14 06:18
Return for Revision
2025-11-14 06:18
Revised
2025-11-28 04:12
Publication Fee Transferred
Second Decision by Editor
2026-01-08 02:48
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-15 10:18
Articles in Press
2026-01-15 10:18
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com